Nolpaza Enteric Tablets 40mg (14 tablets x 2 packs): Effective Relief for Heartburn and Acid Reflux
Find lasting relief from heartburn, acid reflux, and other digestive discomforts with Nolpaza 40mg enteric tablets. This high-quality medication provides powerful and long-lasting symptom relief, helping you enjoy a more comfortable and fulfilling life.
Key Features:
- Effective Relief: Nolpaza effectively reduces stomach acid production, providing quick and lasting relief from heartburn, acid reflux, and other digestive issues.
- Convenient Dosage: Each pack contains 14 enteric-coated tablets, ensuring you have a convenient supply for consistent relief.
- Quality Assurance: Nolpaza is manufactured to the highest standards of quality and safety, ensuring reliable and effective results.
About Nolpaza:
Nolpaza contains pantoprazole sodium sesquihydrate, a proton pump inhibitor that works by blocking the production of stomach acid. It is a commonly prescribed medication for a range of digestive conditions, including:
- Reflux esophagitis: Inflammation of the esophagus caused by stomach acid.
- Symptomatic gastroesophageal reflux disease (GERD): Frequent heartburn and acid reflux.
- Peptic ulcers: Sores in the lining of the stomach or duodenum.
- Zollinger-Ellison syndrome: A rare condition characterized by excessive stomach acid production.
Important Information:
- Consult your doctor: Before using Nolpaza, it is essential to consult with your doctor to determine if it is the right treatment for you.
- Side effects: Like all medications, Nolpaza can cause side effects. Common side effects include headache, dizziness, nausea, diarrhea, and constipation. If you experience any unusual or persistent side effects, contact your doctor immediately.
- Dosage: The recommended dose of Nolpaza is one 40mg tablet daily. Your doctor will determine the appropriate dosage based on your individual needs.
- Storage: Store Nolpaza in a cool, dry place out of reach of children.
Order your Nolpaza enteric tablets today and experience the difference!
Please note: This content is for informational purposes only and should not be considered medical advice. Always consult with your doctor before taking any medication.
| INN | PANTOPRAZOLE |
|---|---|
| The code | 46 076 |
| Side effects | Uncommon (≥ 1/1, 000 to <1/100) sleep disturbances headache, dizziness diarrhea, nausea, vomiting, bloating and flatulence, constipation, dry mouth, abdominal pain, discomfort elevated liver enzymes (transaminases, γ-GT) rash, exanthema, skin rash, itching fractures of the bones of the spine, hip and wrist asthenia, malaise and fatigue Rarely (from ≥ 1/10, 000 to <1/1, 000) agranulocytosis hypersensitivity reactions (including anaphylactic reactions and anaphylactic shock) hyperlipidemia, increased levels of triglycerides, cholesterol, changes in body weight, taste disturbance depression (and all exacerbations) visual disturbances, blurred vision increased bilirubin levels urticaria, Quincke's edema arthralgia, myalgia gynecomastia fever, peripheral edema Very rarely (<1/ 10, 000) thrombocytopenia, leukopenia, confusion (and all associated exacerbations) Not known (cannot be estimated from the available data): hyponatremia, hypomagnesemia hallucinations inations, confusion (especially in genetically predisposed patients, and exacerbation of these symptoms if they existed before treatment) hepatocellular damage, jaundice, hepatocellular insufficiency Stevens-Johnson syndrome, Lyell's syndrome, erythema multiforme, photosensitivity interstitial nephritis |
| Importer | IOOO Interfarmaks 223028 Minsk region, Minsk district, Zhdanovichsky s / s, ag. Zhdanovichi, st. Star, 19a-5, room. 5-2 |
| Composition Means | active substance – pantoprazole sodium sesquihydrate 22.55 mg or 45.10 mg (equivalent to pantoprazole 20 mg or 40 mg, respectively), excipients: mannitol, crospovidone (type B), anhydrous sodium carbonate, sorbitol (E420), calcium stearate, composition enteric coating: hypromellose (2.4-3.6 mPas), povidone (K25), titanium dioxide (E171), iron oxide yellow (E172), propylene glycol, *methacrylic acid-ethyl acrylate copolymer (1:1) 30% dispersion, macrogol 6000, talc |
| Main Active Substances | pantoprazole sodium sesquihydrate 22.55 mg or 45.10 mg |
| Release Form | tablets |
| Application Gender | Any |
| Use during pregnancy and lactation | unknown |
| Contraindications | hypersensitivity to pantoprazole, substituted benzimidazoles or auxiliary components of the drug – combined use with atazanavir |
| Barcode | 3, 84E+12 |
| Indications Applications | For a dosage of 20 mg: Adults and adolescents from 12 years of age and older – symptomatic gastroesophageal reflux disease – for the long-term treatment and prevention of relapse of reflux esophagitis. Adults – prevention of erosive and ulcerative lesions of the stomach and duodenum caused by the use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at increased risk and in need of ongoing treatment with NSAIDs (See section "special instructions") For a dosage of 40 mg Adults and adolescents from 12 years and older – reflux esophagitis Adults – eradication of Helicobacter pylori (H. pylori) in combination with appropriate antibiotic therapy in patients with peptic ulcer associated with H. pylori – peptic ulcer of the stomach and duodenum – Zollinger-Ellison syndrome and other pathological hypersecretory states |
| trade line | Nolpaza |
| Trademark | KRKA |
| Manufacturer | Krka dd, Slovenia |
| Active substance | Pantoprazole |
| Dosage | 40mg |
Related products
Gastrointestinal Health
